Product logo
  • Home
  • Sign Up
Product logo

Sanofi India Ltd

News

Switch to
More ontickertape logoapp
    Home
    Sign Up

    Sanofi India Ltd

    SANOFI
    5,270.1030.15 (-0.57%)
    Investment Checklist
    BasicPro

    Intrinsic value
    Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

    Current price is less than the intrinsic value

    ROE vs FD rates
    Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

    Stock has been generating better return on equity than bank FD

    Dividend Returns
    A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

    Stock offers good dividend returns

    Entry point
    High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

    Good time to consider, as stock is not in overbought zone

    No Red Flags
    ASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks

    Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

    Loading...
    Go pro! Unlock deeper insights
    Get your Zerodha accountOpen Now
    OverviewForecastsFinancialsPeersHoldingsNewsEvents
    1.1 k

    News & Opinions

    1.1 k
    Articles & Videos
    News Thumbnail
    Latest

    Sanofi offers VRS to 800 employees at two units in Telangana

    4 days ago•Economic Times

    News Thumbnail

    Sanofi offers VRS to 800 staffers at India vaccine units amid review

    1 week ago•Business Standard

    News Thumbnail

    Sanofi to let go of staff at vaccine plants in India as part of review

    1 week ago•Economic Times

    News Thumbnail

    Fosun’s sale of Gland Pharma to become India’s biggest pharma deal: Report

    1 month ago•Business Standard

    News Thumbnail

    Buy Sanofi India; target of Rs 6795: Sharekhan

    2 months ago•Moneycontrol

    News Thumbnail

    Hold Sanofi India; target of Rs 6385: ICICI Direct

    3 months ago•Moneycontrol

    News Thumbnail

    Sanofi India Q3 Results Review - Weak Performance, But Healthy Margins: ICICI Securities

    3 months ago•Bloomberg Quint

    News Thumbnail

    Sanofi India posts Rs 131 cr profit in Sept quarter, revenue at Rs 692 cr

    3 months ago•Business Standard

    © Powered byTickertape.ViewSANOFIon 

    EmailHelpBlog

    NSE & BSE – SEBI Registration No: INZ000031633 | CDSL - SEBI  Registration No: IN-DP-431-2019

    Zerodha - NSE & BSE – SEBI Reg. No.: INZ000031633
    Zerodha - CDSL - SEBI Reg. No: IN-DP-431-2019